JAY GERTZ
Professor
Oncological Sciences
- ProfessorOncological Sciences
- Adjunct ProfessorBiomedical Engineering
GRANTS
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTADVANCING HORMONE THERAPY FOR ENDOMETRIAL CANCER8 Aug 2025 - 15 Feb 2027
- EXTERNAL GRANT OR CONTRACTCANCER CENTER SUPPORT GRANT -- GERTZNIH NATIONAL CANCER INSTITUTE1 May 2025 - 15 Nov 2025
- EXTERNAL GRANT OR CONTRACTHUNTSMAN CANCER INSTITUTE POST-BACCALAUREATE PROGRAM IN CANCER RESEARCH1 Jan 2025 - 31 Dec 2027
- EXTERNAL GRANT OR CONTRACTCANCER CENTER SUPPORT GRANT -- GERTZNIH NATIONAL CANCER INSTITUTE1 Aug 2024 - 30 Apr 2025
- EXTERNAL GRANT OR CONTRACTPHASE IV - ANALYSIS OF SHIVANKA COMPOUNDS IMPACT ON GENE EXPRESSION IN HCI-011SHIVANKA RESEARCH LLC27 Jun 2024 - 31 Oct 2024
- EXTERNAL GRANT OR CONTRACTEXPANSION AND CHARACTERIZATION OF HUMAN ENDOMETRIAL CANCER MODELS1 Jun 2024 - 30 Oct 2026
- EXTERNAL GRANT OR CONTRACTTHE COMBINED ROLE OF ARID1A LOSS AND ESTROGEN SIGNALING IN ENDOMETRIAL CANCER4 Mar 2024 - 28 Feb 2029
- EXTERNAL GRANT OR CONTRACTPHASE III - ANALYSIS OF SHIVANKA COMPOUNDS IMPACT ON GENE EXPRESSION IN ER WILDTYPE AND MUTANT BREAST CANCER MODELS27 Sep 2023 - 26 Jan 2024
- EXTERNAL GRANT OR CONTRACTMOLECULAR CROSSTALK BETWEEN ESTROGENS AND PROGESTOGENS IN ENDOMETRIAL CANCER1 Sep 2023 - 31 Aug 2027
- EXTERNAL GRANT OR CONTRACTPROGESTIN THERAPY FOR ENDOMETRIAL CANCER1 Aug 2023 - 31 Jul 2027
- EXTERNAL GRANT OR CONTRACTMECHANISMS OF TAMOXIFEN-ASSOCIATED ENDOMETRIAL CANCER RISKNIH NATIONAL CANCER INSTITUTE1 May 2023 - 30 Apr 2026
- EXTERNAL GRANT OR CONTRACTPHASE II PART I - ANALYSIS OF PRO-FULVESTRANT LEAD METABOLITES ON ER ACTIVITY IN ER WILDTYPE AND MUTANT BREAST CANCER CELL LINES1 Jan 2023 - 30 Jul 2023
- EXTERNAL GRANT OR CONTRACTIN VIVO MULTIPLEXED SILENCING OF CIS-ELEMENTS IN THE BRAIN1 May 2021 - 30 Apr 2024
- EXTERNAL GRANT OR CONTRACTGERTZ_SERMONIX PHARMACEUTICALSERMONIX PHARMACEUTICALS INC4 Jan 2021 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTTHE ROLE OF REGULATORY PROTEINS IN ESTROGEN RECEPTOR ALPHA MUTANT BREAST CANCER1 Aug 2019 - 31 Jul 2023
- EXTERNAL GRANT OR CONTRACTGERTZ_ZENO_SERDZENO MANAGEMENT INC.9 May 2019 - 9 May 2020
- EXTERNAL GRANT OR CONTRACTMOLECULAR MODELING OF ESTROGENARMY MEDICAL RESEARCH ACQUISIT1 Jan 2016 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTRNA-BASED BIOMARKERSNIH NATIONAL CANCER INSTITUTE9 Jan 2015 - 31 Dec 2019